Concepedia

Renzo Cescato

RC

43

Publications

3.3K

Citations

26

H-Index

1995

Active since

Affiliations

University of Bern(Current)

University Hospital of Basel

Salk Institute for Biological Studies

Clayton Foundation

Novartis (Switzerland)

Renzo Cescato is an author at University of Bern specializing in medicine, pharmacology, and radiation oncology.

Top concepts

Publications per year

1995–2016

43

Publications

43

Radiolabeled somatostatin receptor antagonists are preferable to agonists for<i>in vivo</i>peptide receptor targeting of tumors

Mihaela Ginj, Hanwen Zhang, Beatrice Waser et al. · Proceedings of the National Academy of Sciences · 2006 · 488 citations · Full text

, , +22

Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting

Renzo Cescato, Berthold A. Nock, Anastasia Nikolopoulou et al. · Journal of Nuclear Medicine · 2008 · 289 citations · Full text

PET of Somatostatin Receptor–Positive Tumors Using <sup>64</sup>Cu- and <sup>68</sup>Ga-Somatostatin Antagonists: The Chelate Makes the Difference

Melpomeni Fani, Luigi Del Pozzo, K. Abiraj et al. · Journal of Nuclear Medicine · 2011 · 255 citations

Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours

Rosalba Mansi, Xuejuan Wang, Flavio Forrer et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 197 citations · Full text

, , +11

Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.

Renzo Cescato, Stefan Schulz, Beatrice Waser et al. · PubMed · 2006 · 185 citations

Rows per page

1–5 of 43